LGVN - Longeveron Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.8 0.03 (3.79%)	---	---	---	0.0 (0.04%)	0.02 (2.65%)	0.01 (1.54%)	0.01 (1.54%)

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.34
Diluted EPS:: -0.34
Basic P/E:: -2.4412
Diluted P/E:: -2.4412
RSI(14) 1m:: 100.0
VWAP:: 0.83
RVol:: 0.7389

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	0.82 -0.01 (-1.56%)	Oct 15 15:59
1m	Price decrease 1m	0.81 -0.01 (-1.75%)	Oct 15 11:32
1m	Price decrease 1m	0.81 -0.01 (-1.47%)	Oct 15 10:01
1m	Price increase 1m	0.83 +0.01 (+1.02%)	Oct 15 09:42
1m	Price decrease 1m	0.8 -0.02 (-2.15%)	Oct 15 09:38